Centrix Pharma Solutions is a UK-based, development-focused CDMO specialising in early-stage drug product development and clinical trial manufacturing for orally delivered small molecules.
 
Built on the heritage of Custom Pharma Services (established in 1979), Centrix was created to support the most critical stages of drug development. guiding innovative biotech companies from concept to clinic with confidence. Our approach is rooted in deep pharmaceutical science, patient-centric design, and proactive risk management, ensuring drug products are designed right from the start.
 
We work as a genuine partner to our clients, combining formulation development, analytical strategy, and GMP clinical manufacturing within an integrated, agile model. By aligning product and patient requirements early, we help reduce rework, control timelines, and de-risk progression into first-in-human and later-phase clinical studies.
 
Centrix is trusted by early-stage and virtual biotech companies seeking flexibility, transparency, and direct access to experienced scientists. With a focus on collaboration and scientific integrity, we don’t just deliver services. we help turn promising molecules into patient-ready medicines.
 
Molecule First. Patient Always.

By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to: Improve human health, Engineer biology and Enable traits discovery.

Club Quarters Hotels are full service hotels located in world-class cities in the U.S. and London. Designed for business and urban travelers, we have the accommodations, amenities and services needed to make your stay productive, enjoyable, and hassle-free.

Concept Life Sciences is a leading contract research organisation (CRO) serving the global life sciences industry. For over 25 years, the company, and its heritage companies, have provided consultative and collaborative drug discovery and development services. Our approach, supported by passionate scientists and world-leading capabilities, enables clients to overcome complex scientific challenges across a broad range of therapeutic areas, improving program success rates. The company has successfully helped 29 candidates advance to the clinic. 

The company offers sophisticated translational biology services coupled with exceptional end-to-end chemistry capabilities across all modalities including small molecules, biologics, peptides and cell & gene therapies, with the ability to seamlessly integrate capabilities and provide bespoke solutions to address client needs. 

Collectively, the company’s high-quality services and commitment to customer service across the drug development pathway enhances efficiency in drug discovery, helping clients advance their drugs to clinic in as little as 32 months, well ahead of the industry average of 60 months. 
Driven by a passion for science, Concept Life Sciences has around 230 employees, with around 70% holding PhDs. The company operates from state-of-the-art UK facilities, headquartered near Manchester, with additional operations in Edinburgh, Dundee, and Sandwich. The headquarters is one of the UK’s largest medicinal chemistry CRO sites with key discovery services all under one roof.  

Visit us at www.conceptlifesciences.com and follow us on LinkedIn.

Covve is an innovative technology company that specializes in intelligent contact management solutions. At Covve we help professionals build meaningful relationships through our world-class leading products:

●      Personal CRM    You can check it out here!

●      Digital Business Card  You can check it out here!

●      Business Card Scanner You can check it out here!

Our Personal CRM and our proprietary, accuracy-leading Business Card Scanner are rated Number One (1) and in the Top Five (5) in US App Stores respectively. Our Digital Business Cards cater to the diverse professional needs of more than one hundred (100+) global corporate clients. 

We offer a 20% discount on all our products to BioPartner UK Members or Alliance Partners.

Deliver Bio is developing a targeted gene delivery technology using nanoparticles. We are focussed on delivering genes to target cells/organs within patients (in vivo) with high specificity and efficiency with no accumulation in unwanted organs.

We create technologies that drive human progress.

Our story began with a belief and a passion: that everybody should have easy access to the best technology anywhere in the world. That was in 1984 in Michael Dell’s University of Texas dorm room. Today, Dell Technologies is instrumental in changing the digital landscape the world over. 

We are among the world’s leading technology companies helping to transform people’s lives with extraordinary capabilities. From hybrid cloud solutions to high-performance computing to ambitious social impact and sustainability initiatives, what we do impacts everyone, everywhere.

We work with clients, who range from Top 5 Pharma companies to SMEs, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.

We pride ourselves on our understanding of clients’ needs and our flexible, creative and pragmatic approach puts our clients and the patients they serve at the centre of everything we do.

Selcia, now part of Eurofins, is a global leader in 14C custom radiolabelling, stable isotope labelling and analytical services. With many years of experience our team of expert synthetic radiochemists can prepare radiolabelled molecules of almost any complexity for use in regulatory studies by the life sciences and chemical industries to understand: preclinical and clinical drug metabolism, human mass balance (GMP 14C Radiolabelled API), dermal penetration, tissue distribution and environmental fate. Selcia also offers GLP NMR and analytical problem solving services to support regulatory submissions, as well as the profiling and synthesis of metabolites and process impurities.  www.selcia.com 

• 14C Custom Radiolabelling for pre-clinical studies (ADME, Dermal Penetration, E-fate)  
• GMP Radiolabelled API for Clinical Trials , 14C-API for hAME and mass balance  
• Stable Labelling  (13C, 2H, 15N) Internal Standards, Metabolites and Impurities  
• GLP Analysis Certification and Problem Solving including GLP NMR 

Radiolabelling to support Life Sciences: • Metabolism • Distribution • Mass Balance • Micro-dosing • Environmental fate • Dermal Penetration 

Evestia Clinical is a global, mid‑size CRO dedicated to supporting life science innovators from Phase I to IV through a single‑partner model.  They provide a flexible, tailored suite of clinical trial services, from single service or FSP to full‑service, with primary focus in oncology, neurology, and rare diseases, and additional expertise in immunology and inflammation.

Anchored by a core presence in the US, UK, Europe, and Australia, Evestia Clinical delivers fast start‑up, pragmatic execution, and integrated study services, helping bring life‑changing therapies to patients sooner.